- Home
- KELYA vs FBRX Comparison
KELYA vs FBRX Comparison
Compare KELYA & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KELYA | FBRX |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.4M | 367.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KELYA | FBRX |
|---|---|---|
| Price | $10.61 | $34.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $16.00 | ★ $67.00 |
| AVG Volume (30 Days) | ★ 424.7K | 231.8K |
| Earning Date | 02-13-2026 | 11-14-2025 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,392,800,000.00 | N/A |
| Revenue This Year | $0.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.46 | N/A |
| 52 Week Low | $7.98 | $4.90 |
| 52 Week High | $15.11 | $35.62 |
Technical Indicators
Market Signals| Indicator | KELYA | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 62.07 |
| Support Level | $9.84 | $26.66 |
| Resistance Level | $11.39 | $35.50 |
| Average True Range (ATR) | 0.39 | 3.44 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 59.14 | 92.13 |
Price Performance
Historical ComparisonAbout KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).